DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
Clinical trial NCT04042701 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04042701
- Sponsor
- Daiichi Sankyo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2025-07-21
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.